Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by scroll4facts


NRIFF

Top pick out of 182 companies

Go between 2:20 and 2:45 in the interview below: http://smallcappower.com...

May 19, 2016

NRIFF

Letter to shareholders

The letter to shareholders has been updated today. Nuvo is having ongoing...

May 12, 2016

NRIFF

P2 average total bottles/week sold is about 10 000 in april

See the Investor Presentation dated May 9.

May 9, 2016

NRIFF

Strong performance of PENNSAID 2%

"Primary Care Business Unit: PENNSAID 2% sales in the first quarter...

May 9, 2016

NRIFF

RE:Forecast Q2 and 2016 P2 sales

I suppose those strong sales numbers along with the positive results from the...

April 12, 2016

NRIFF

RE:Nuvo Posts Letter to Shareholders

Great finding. Thank you for posting. I fully agree with your comments. ...

April 5, 2016

NRIFF

RE:Nuvo Nightmare

When you say:   "Not even a single offer for P2 ROW", ...

April 5, 2016

NRIFF

RE:RE:A global brand

PWC was contracted for identifying, contacting and qualifying potential...

April 4, 2016

NRIFF

RE:A global brand

Typo.   From this morning PR:

April 4, 2016

NRIFF

A global brand

From this monring PR:   "Our goal and Jesse's first priority...

April 4, 2016

NRIFF

"Cash flow positive and profitable"

Taken from p.5 of the updated Investor Presentation dated March 31 2016...

April 3, 2016

NRIFF

RE:RE:Bigzig said ....

I still believe that P2 is a significantly superior product than ordinary...

April 2, 2016

NRIFF

RE:Takeover Anytime Soon?

I don't know what will come first. Takeover, M&A, or hopefully a...

April 1, 2016

NRIFF

RE:Endo hits 52 Week Low.....Generic impact

Right.  Sad news for Endp. Fortunately,  I think this an excellent...

April 1, 2016

NRIFF

RE:Another Negative Day

Class action suits take forever to settle when they do and those are not...

March 30, 2016

NRIFF

Analyst coverage

They added LBS on their website

March 30, 2016

NRIFF

RE:Out-licensing could trigger the next catalyst

Correction.. "With Q4 2015 annualized net sales of $221.6M USD (aprx...

March 29, 2016

NRIFF

Out-licensing could trigger the next catalyst

This pharma got $45M USD cash from Hznp for Pennsaid sales and marketing...

March 29, 2016

NRIFF

RE:Q1........By the Numbers

In your little projection I guess you took half  the Q4 2015 product...

March 27, 2016

NRIFF

"Subpoena Appears Benign"

Interesting comments and point of view: http://www.streetinsider.com/Analyst...

March 25, 2016

Prev 1 2 3 4 5 Next

Featured Company